NEW YORK, May 23 - Pyrosequencing on Wednesday took a step closer to entering the diagnostics market, announcing that it had received a patent for assessing cardiovascular conditions such as myocardial infarction and stroke.

“This is extraordinarily important – it establishes us as a player in diagnostics in the cardiovascular area,” Jerry Williamson, vice president of global diagnostics, told GenomeWeb.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.